Connection

Jason Trubiano to Humans

Back to Details
This is a "connection" page, showing publications Jason Trubiano has written about Humans.
Jason Trubiano
Connection Strength
0.156
Humans
  1. Risk factors for readmission following inpatient management of COVID-19 in a low-prevalence setting. Intern Med J. 2021 05; 51(5):821-823.
    View in: PubMed
    Score: 0.008
  2. Evolution of the Human Cytokine Response from Acute Illness to Disease Resolution in SARS-Cov-2 Infection-Implications for Therapeutic Monitoring and Therapeutic Targets. J Clin Immunol. 2021 08; 41(6):1162-1164.
    View in: PubMed
    Score: 0.008
  3. The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study. Front Immunol. 2021; 12:646095.
    View in: PubMed
    Score: 0.007
  4. COVID-MATCH65-A prospectively derived clinical decision rule for severe acute respiratory syndrome coronavirus 2. PLoS One. 2020; 15(12):e0243414.
    View in: PubMed
    Score: 0.007
  5. Alterations in Smell or Taste-Classic Coronavirus Disease 2019? Clin Infect Dis. 2020 11 19; 71(16):2307-2309.
    View in: PubMed
    Score: 0.007
  6. The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection. J Allergy Clin Immunol. 2020 09; 146(3):518-534.e1.
    View in: PubMed
    Score: 0.007
  7. Antimicrobial anaphylaxis: the changing face of severe antimicrobial allergy. J Antimicrob Chemother. 2020 01 01; 75(1):229-235.
    View in: PubMed
    Score: 0.007
  8. Beta-Lactam and Sulfonamide Allergy Testing Should Be a Standard of Care in Immunocompromised Hosts. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2151-2153.
    View in: PubMed
    Score: 0.007
  9. Antibiotic allergy testing improves antibiotic appropriateness in patients with cancer. J Antimicrob Chemother. 2018 11 01; 73(11):3209-3211.
    View in: PubMed
    Score: 0.006
  10. The safety of antibiotic skin testing in severe T-cell-mediated hypersensitivity of immunocompetent and immunocompromised hosts. J Allergy Clin Immunol Pract. 2019 04; 7(4):1341-1343.e1.
    View in: PubMed
    Score: 0.006
  11. Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients. Transpl Infect Dis. 2018 Dec; 20(6):e12968.
    View in: PubMed
    Score: 0.006
  12. How antibiotic allergy labels may be harming our most vulnerable patients. Med J Aust. 2018 06 18; 208(11):469-470.
    View in: PubMed
    Score: 0.006
  13. Persistence of Penicillin Allergy-Reply. JAMA. 2017 11 07; 318(17):1714-1715.
    View in: PubMed
    Score: 0.006
  14. The Combined Utility of Ex Vivo IFN-? Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions. J Allergy Clin Immunol Pract. 2018 Jul - Aug; 6(4):1287-1296.e1.
    View in: PubMed
    Score: 0.006
  15. The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration. J Allergy Clin Immunol Pract. 2017 Nov - Dec; 5(6):1532-1542.
    View in: PubMed
    Score: 0.006
  16. Penicillin Allergy Is Not Necessarily Forever. JAMA. 2017 Jul 04; 318(1):82-83.
    View in: PubMed
    Score: 0.006
  17. Impact of an Integrated Antibiotic Allergy Testing Program on Antimicrobial Stewardship: A Multicenter Evaluation. Clin Infect Dis. 2017 07 01; 65(1):166-174.
    View in: PubMed
    Score: 0.006
  18. Incidence, etiology and timing of infections following azacitidine therapy for myelodysplastic syndromes. Leuk Lymphoma. 2017 Oct; 58(10):2379-2386.
    View in: PubMed
    Score: 0.006
  19. Coxiella burnetii endocarditis after Q fever vaccination. J Med Microbiol. 2012 Dec; 61(Pt 12):1775-1779.
    View in: PubMed
    Score: 0.004
  20. Staff to staff transmission as a driver of healthcare worker infections with COVID-19. Infect Dis Health. 2021 11; 26(4):276-283.
    View in: PubMed
    Score: 0.002
  21. Identifying patterns in unplanned hospital admissions during the COVID-19 pandemic: a single-centre retrospective study. Intern Med J. 2021 06; 51(6):868-872.
    View in: PubMed
    Score: 0.002
  22. CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity. Immunity. 2021 05 11; 54(5):1066-1082.e5.
    View in: PubMed
    Score: 0.002
  23. A pilot double-blind safety and feasibility randomized controlled trial of high-dose intravenous zinc in hospitalized COVID-19 patients. J Med Virol. 2021 May; 93(5):3261-3267.
    View in: PubMed
    Score: 0.002
  24. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses. Cell Rep Med. 2021 03 16; 2(3):100208.
    View in: PubMed
    Score: 0.002
  25. Randomised controlled trial for high-dose intravenous zinc as adjunctive therapy in SARS-CoV-2 (COVID-19) positive critically ill patients: trial protocol. BMJ Open. 2020 Dec 02; 10(12):e040580.
    View in: PubMed
    Score: 0.002
  26. Ventilation perfusion lung SPECT/CT in pregnancy during COVID-19. Intern Med J. 2020 12; 50(12):1588-1590.
    View in: PubMed
    Score: 0.002
  27. An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Oct 13; 21(1):847.
    View in: PubMed
    Score: 0.002
  28. Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection. Pathology. 2020 Dec; 52(7):778-782.
    View in: PubMed
    Score: 0.002
  29. COVID-19: collaboration will keep us ahead of the curve. Intern Med J. 2020 07; 50(7):784-786.
    View in: PubMed
    Score: 0.002
  30. HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms. J Allergy Clin Immunol. 2019 07; 144(1):183-192.
    View in: PubMed
    Score: 0.002
  31. Antibiotic allergy. Lancet. 2019 01 12; 393(10167):183-198.
    View in: PubMed
    Score: 0.002
  32. Review of epiglottitis in the post Haemophilus influenzae type-b vaccine era. ANZ J Surg. 2018 11; 88(11):1135-1140.
    View in: PubMed
    Score: 0.002
  33. Medication-related anaphylaxis treated in hospital: Agents implicated, patient outcomes, and management lessons. Pharmacoepidemiol Drug Saf. 2018 09; 27(9):1029-1033.
    View in: PubMed
    Score: 0.002
  34. Fulminant meningococcal sepsis due to non-groupable Neisseria meningitidis in a patient receiving eculizumab. Med J Aust. 2018 06 18; 208(11):478-479.
    View in: PubMed
    Score: 0.002
  35. Drug-induced liver injury is frequently associated with severe cutaneous adverse drug reactions: experience from two Australian tertiary hospitals. Intern Med J. 2018 05; 48(5):549-555.
    View in: PubMed
    Score: 0.002
  36. The incubation period of Buruli ulcer (Mycobacterium ulcerans infection) in Victoria, Australia - Remains similar despite changing geographic distribution of disease. PLoS Negl Trop Dis. 2018 03; 12(3):e0006323.
    View in: PubMed
    Score: 0.002
  37. Short Communication: Mycobacterium avium Complex Infection and Immune Reconstitution Inflammatory Syndrome Remain a Challenge in the Era of Effective Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2017 12; 33(12):1202-1204.
    View in: PubMed
    Score: 0.001
  38. Ibrutinib may impair serological responses to influenza vaccination. Haematologica. 2017 10; 102(10):e397-e399.
    View in: PubMed
    Score: 0.001
  39. Risks factors and outcomes of Clostridium difficile infection in patients with cancer: a matched case-control study. Support Care Cancer. 2017 06; 25(6):1923-1930.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.